165 related articles for article (PubMed ID: 34685622)
1. The Pro-Survival Oct4/Stat1/Mcl-1 Axis Is Associated with Poor Prognosis in Lung Adenocarcinoma Patients.
Su YC; Chen YC; Tseng YL; Shieh GS; Wu P; Shiau AL; Wu CL
Cells; 2021 Oct; 10(10):. PubMed ID: 34685622
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
[TBL] [Abstract][Full Text] [Related]
3. Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma.
Liao WC; Lin TJ; Liu YC; Wei YS; Chen GY; Feng HP; Chang YF; Chang HT; Wang CL; Chi HC; Wang CI; Lin KH; Ou Yang WT; Yu CJ
Cancer Sci; 2022 Jan; 113(1):205-220. PubMed ID: 34773335
[TBL] [Abstract][Full Text] [Related]
4. CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis.
Yu SK; Yu T; Wang YM; Sun A; Liu J; Lu KH
J Transl Med; 2024 May; 22(1):460. PubMed ID: 38750462
[TBL] [Abstract][Full Text] [Related]
5. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
[TBL] [Abstract][Full Text] [Related]
6. Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer.
Feng YH; Su YC; Lin SF; Lin PR; Wu CL; Tung CL; Li CF; Shieh GS; Shiau AL
BMC Cancer; 2019 Aug; 19(1):791. PubMed ID: 31399076
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
[TBL] [Abstract][Full Text] [Related]
8. Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response.
Whitsett TG; Mathews IT; Cardone MH; Lena RJ; Pierceall WE; Bittner M; Sima C; LoBello J; Weiss GJ; Tran NL
Mol Cancer Res; 2014 Apr; 12(4):550-9. PubMed ID: 24469836
[TBL] [Abstract][Full Text] [Related]
9. MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers.
Radhakrishnan H; Ilm K; Walther W; Shirasawa S; Sasazuki T; Daniel PT; Gillissen B; Stein U
Cancer Lett; 2017 Sep; 403():231-245. PubMed ID: 28649004
[TBL] [Abstract][Full Text] [Related]
10. IL-10 suppresses IFN-γ-mediated signaling in lung adenocarcinoma.
Gao Y; Lu J; Zeng C; Yang J; Huang B; Zhang N; Li L; Fu X
Clin Exp Med; 2020 Aug; 20(3):449-459. PubMed ID: 32306136
[TBL] [Abstract][Full Text] [Related]
11. Silencing of
Xiao L; Li Y; Zeng X; Zhou Z; Hu S; Zhang S; Zhou Y; Zhang Z; Zhao H; Zhao H; Beer DG; Mao R; Chen G
Aging (Albany NY); 2020 Dec; 13(2):2539-2552. PubMed ID: 33318313
[TBL] [Abstract][Full Text] [Related]
12. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
[TBL] [Abstract][Full Text] [Related]
13. Lung adenocarcinoma resistance to therapy with EGFR‑tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG.
Hu F; Li C; Zheng X; Zhang H; Shen Y; Zhou L; Yang X; Han B; Zhang X
Oncol Rep; 2020 Feb; 43(2):727-735. PubMed ID: 31894290
[TBL] [Abstract][Full Text] [Related]
14. STAT1-induced upregulation of LINC00467 promotes the proliferation migration of lung adenocarcinoma cells by epigenetically silencing DKK1 to activate Wnt/β-catenin signaling pathway.
Yang J; Liu Y; Mai X; Lu S; Jin L; Tai X
Biochem Biophys Res Commun; 2019 Jun; 514(1):118-126. PubMed ID: 31027730
[TBL] [Abstract][Full Text] [Related]
15. [miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene].
Zhang S; Wu Y; Feng D; Zhang Z; Jiang F; Yin R; Xu L
Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):317-22. PubMed ID: 21496429
[TBL] [Abstract][Full Text] [Related]
16. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer.
Wen Q; Zhan Y; Zheng H; Zang H; Luo J; Zhang Y; Wang W; Feng J; Lu J; Chen L; Fan S
Diagn Pathol; 2019 Oct; 14(1):108. PubMed ID: 31601252
[TBL] [Abstract][Full Text] [Related]
18. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
[TBL] [Abstract][Full Text] [Related]
19. Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness.
Chang YC; Yang YF; Chiou J; Tsai HF; Fang CY; Yang CJ; Chen CL; Hsiao M
Cell Death Dis; 2020 Mar; 11(3):195. PubMed ID: 32188842
[TBL] [Abstract][Full Text] [Related]
20. Silencing tankyrase and telomerase promotes A549 human lung adenocarcinoma cell apoptosis and inhibits proliferation.
Lu H; Lei Z; Lu Z; Lu Q; Lu C; Chen W; Wang C; Tang Q; Kong Q
Oncol Rep; 2013 Oct; 30(4):1745-52. PubMed ID: 23933993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
